Patent · US Active

Identification of tumors

US10538816B2 · kind B2 · utility

1Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 2, 2016
Grant dateJan 21, 2020
Priority date
Expiry dateDec 2, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B40/00
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

The invention provides methods for the use of gene expression measurements to classify or identify tumors in samples obtained from a subject in a clinical setting, such as in cases of formalin fixed, paraffin embedded (FFPE) samples.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.